Alkem Laboratories added 1.93% to Rs 4,795 after the company announced that the United States Food and Drug Administration (USFDA) conducted a Bioresearch Monitoring (BIMO) inspection at its ...

The uptick in the Zydus Life shares came after the company received final approval from the USFDA to manufacture Eluxadoline ...

As global markets navigate uncertainties around trade policies and economic growth, Asian markets are capturing attention with their potential for stability and income generation through dividend ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...

Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

Pharmaceutical manufacturers are padding their wallets while rural families and retirees are squeezed by a system designed to benefit shareholders, not patients,” writes Tonja Hanson in an op-ed.

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service.

As Filipinos increasingly prioritize health and wellness, Sole Pharma, a leading European pharmaceutical manufacturer, ...